Effects of a personalized exercise prescription after kidney transplantation

Effects of tailored physical activity after kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN66295470

Enrollment

102

Registered

2017-01-19

Start date

2011-07-20

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplant recipients Urological and Genital Diseases Kidney transplant recipients

Interventions

Patients recruited from different transplant centers are divided into two groups: the cases group (Group A), in which personalized physical activity is prescribed by the sports physicians, and the con

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Kidney recipients six months after organ transplantation 2. Clinically and functionally stable 3. Aged between 18 and 60 years

Exclusion criteria

Exclusion criteria: 1. Orthopaedic limitations 2. Psychiatric or neurological disorders 3. Proteinuria in nephrotic range 4. Low compliance to treatment 5. Any cardiovascular contraindication to exercise testing and training

Design outcomes

Primary

Measure	Time frame
Type and modality of administration of physical exercise resulting more effective in terms of improving exercise capacity (cardiorespiratory fitness) in transplant recipients (related to preservation and graft function), measured during an incremental exercise and expressed as peak oxygen consumption (V’O2peak) that is demonstrated to be a strong predictor of CVD events, at baseline, 6 and 12 months.	—

Measure

Time frame

Type and modality of administration of physical exercise resulting more effective in terms of improving exercise capacity (cardiorespiratory fitness) in transplant recipients (related to preservation and graft function), measured during an incremental exercise and expressed as peak oxygen consumption (V’O2peak) that is demonstrated to be a strong predictor of CVD events, at baseline, 6 and 12 months.

—

Secondary

Measure	Time frame
1. Type and modality of physical exercise assessed by dynamic muscular strength tests (1RM measured using a leg press (Technogym, Cesena, Italy) for lower limb and free weights for upper limb), the power of the lower limbs measured indirectly from the fly time of a Counter Movement Jump (CMJ), at baseline, 6 and 12 months 2. Quality of life measured by the Medical Outcomes Study Short Form Questionnaire (SF-36) at baseline, 6 and 12 months 3. Morbidity and health status of kidney transplanted population measured by Creatinine (mg/dL) with Jaffè method, proteinuria (mg/1000 mL) with turbidimetry method at baseline, 6 and 12 months 4. Estimated Glomerular Filtration Rate (eGFR) with Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at baseline, 6 and 12 months	—

Measure

Time frame

1. Type and modality of physical exercise assessed by dynamic muscular strength tests (1RM measured using a leg press (Technogym, Cesena, Italy) for lower limb and free weights for upper limb), the power of the lower limbs measured indirectly from the fly time of a Counter Movement Jump (CMJ), at baseline, 6 and 12 months 2. Quality of life measured by the Medical Outcomes Study Short Form Questionnaire (SF-36) at baseline, 6 and 12 months 3. Morbidity and health status of kidney transplanted population measured by Creatinine (mg/dL) with Jaffè method, proteinuria (mg/1000 mL) with turbidimetry method at baseline, 6 and 12 months 4. Estimated Glomerular Filtration Rate (eGFR) with Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at baseline, 6 and 12 months

—

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026